European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

7 EU fundings (€0.00): Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076 … Bdl Year 2017 EU Research and Innovation programme "Horizon"

Text

District Court of Cologne HRB 48248

01/01/2017 EU funding (€12M): Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106
01/01/2017 EU funding (€20.2M): Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026
01/09/2017 EU funding (€20M): Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management
01/02/2017 EU funding (€3,549,833): Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055
01/01/2017 EU funding (€7,370,000): ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064
01/09/2017 EU funding (€8,025,000): Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076
01/03/2017 EU funding (€9,664,970): Big Data 4 Better Hearts - Sofia ref.: 116074
tax haven banner

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Bayer AG, Leverkusen, Germany.

Printing is only available to North Data premium service subscribers.